Lipoprotein(a) in patients with acute cerebral ischemia.

BACKGROUND AND PURPOSE In several cross-sectional studies, a high serum lipoprotein(a) [Lp(a)] level was found to be an independent risk factor for cerebral infarction. In a recent prospective study, however, no association was found between Lp(a) levels at baseline and future risk of stroke. Whether Lp(a) is a prognostic factor in a high-risk population of patients with acute ischemic stroke remains unclear. METHODS We assessed Lp(a) level on admission to study its relationship with cardiovascular risk profile, stroke severity, and prognosis in 151 consecutive patients with acute cerebral ischemia. The mean follow-up period was 2.5 +/- 1.2 years. Lp(a) was measured by means of a solid-phase two-site immunoradiometric assay. RESULTS Increased Lp(a) levels were found in 53 (35%) of the patients with cerebral ischemia. Median (5th and 95th percentile) values of Lp(a) were 191 (12 and 1539) mg/L and 197 (10 and 1255) mg/L for patients with transient ischemic attack and patients with ischemic stroke, respectively. No relationship was found between Lp(a) levels and stroke severity (P=.68) or the occurrence of vascular events during follow-up (P log rank=0.81). CONCLUSIONS We conclude that Lp(a) is increased in about one third of patients with acute cerebral ischemia, but it does not appear to be associated with the cardiovascular risk profile, stroke characteristics, or the prognosis of such patients.

[1]  P. Ridker,et al.  Plasma concentration of lipoprotein(a) and the risk of future stroke. , 1995, JAMA.

[2]  D. Rader,et al.  The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. , 1995, The Journal of clinical investigation.

[3]  K. Berg,et al.  Changes in Lp(a) lipoprotein and other plasma proteins during acute myocardial infarction , 1994, Clinical genetics.

[4]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice , 1994 .

[5]  L. Chambless,et al.  Lipoprotein(a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: the ARIC Study. Atherosclerosis Risk in Communities. , 1994, Annals of epidemiology.

[6]  Y. Shinohara,et al.  Lipoprotein(a) and Ischemic Cerebrovascular Disease in Young Adults , 1994, Stroke.

[7]  M. Seishima,et al.  Lp(a): an acute-phase reactant? , 1994, Chemistry and physics of lipids.

[8]  P. Ridker,et al.  A prospective study of lipoprotein(a) and the risk of myocardial infarction. , 1993, JAMA.

[9]  P. Koudstaal,et al.  Hyperglycemia in the Acute Phase of Stroke Is Not Caused by Stress , 1993, Stroke.

[10]  H. Hamaguchi,et al.  High Serum Lipoprotein (a) Levels Are an Independent Risk Factor for Cerebral Infarction , 1993, Stroke.

[11]  D. Rader,et al.  Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production. , 1993, The Journal of clinical investigation.

[12]  A. Jovicić,et al.  Lipoprotein(a) in patients with carotid atherosclerosis and ischemic cerebrovascular disorders. , 1993, Atherosclerosis.

[13]  W. März,et al.  Determination of Lipoprotein(a): Evaluation of Three Methods , 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[14]  B. Norrving,et al.  Plasma lipids and lipoproteins in subtypes of stroke , 1992, Acta neurologica Scandinavica.

[15]  M. Sentí,et al.  Lipoprotein and Apolipoprotein Profile in Men With Ischemic Stroke: Role of Lipoprotein (a), Triglyceride‐Rich Lipoproteins, and Apolipoprotein E Polymorphism , 1992, Stroke.

[16]  E. Boerwinkle,et al.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. , 1992, The Journal of clinical investigation.

[17]  G. Dahlén,et al.  Lipoprotein(a) and acute-phase proteins in acute myocardial infarction. , 1992, Scandinavian journal of clinical and laboratory investigation.

[18]  R. Lawn,et al.  Lipoprotein(a) and atherosclerosis. , 1991, Annals of internal medicine.

[19]  J. Huttunen,et al.  Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. , 1991, Atherosclerosis.

[20]  J. Bamford,et al.  Classification and natural history of clinically identifiable subtypes of cerebral infarction , 1991, The Lancet.

[21]  G L Myers,et al.  Establishment of Reference Methods for Lipids, Lipoproteins and Apolipoproteins , 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[22]  J. Woo,et al.  Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese. , 1991, Stroke.

[23]  L. Wilhelmsen,et al.  Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.

[24]  E. Boerwinkle,et al.  Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. , 1990, The New England journal of medicine.

[25]  G. Assmann,et al.  Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. , 1990, Clinical chemistry.

[26]  James Scott.  Thrombogenesis linked to atherogenesis at last? , 1989, Nature.

[27]  M. Seishima,et al.  Transient changes of serum lipoprotein(a) as an acute phase protein. , 1989, Atherosclerosis.

[28]  J. Breslow,et al.  Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis , 1989, Nature.

[29]  G. Luc,et al.  Characterization of five mouse monoclonal antibodies to apolipoprotein[a] from human Lp[a]: evidence for weak plasminogen reactivity. , 1989, Journal of lipid research.

[30]  L. Romics,et al.  Lipoprotein (a) and plasminogen are immunochemically related. , 1988, Biochimica et biophysica acta.

[31]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[32]  N. Hilschmann,et al.  Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. , 1987, Biological chemistry Hoppe-Seyler.

[33]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[34]  G. Utermann,et al.  Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. , 1987, The Journal of clinical investigation.

[35]  G. Jürgens,et al.  Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. , 1987, Neurology.

[36]  N. Morton,et al.  Lp(a) lipoprotein as a risk factor for myocardial infarction. , 1986, JAMA.

[37]  K. Pfeiffer,et al.  Lipoprotein(a) as a strong indicator for cerebrovascular disease. , 1986, Stroke.

[38]  P. Koudstaal,et al.  Diagnosis of transient ischemic attacks: improvement of interobserver agreement by a check-list in ordinary language. , 1986, Stroke.

[39]  M. Kameyama,et al.  Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. , 1986, Atherosclerosis.

[40]  V. Armstrong,et al.  Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). , 1985, Journal of lipid research.

[41]  H. Damasio,et al.  A computed tomographic guide to the identification of cerebral vascular territories. , 1983, Archives of neurology.

[42]  E Marth,et al.  Lipoprotein Lp(a) and the risk for myocardial infarction. , 1981, Atherosclerosis.

[43]  M. Frick,et al.  Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease , 1974, Clinical genetics.

[44]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[45]  J. Goodwin,et al.  Spectrophotometry of proline in plasma and urine. , 1972, Clinical chemistry.